Steen Hoffmann

Steen Hoffmann

Auto-generated profile, based on publicly available information

Steen Hoffmann

Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2023 in Eurosurveillance
Verified
Journal Article
Open access
TJThor Bech Johannesen
Thor Bech Johannesen
CMCharlotte Munkstrup
Charlotte Munkstrup
SESofie Edslev
Sofie Edslev
SBSharmin Baig
Sharmin Baig
SNStine Nielsen
Stine Nielsen
MSMarc Stegger
Marc Stegger
A highly virulent sub-lineage of the Streptococcus pyogenes M1 clone has been rapidly expanding throughout Denmark since late 2022 and now accounts for 30% of the new invasive group A streptococcal infections. We aimed to investigate whether a shift in variant composition can account for the high incidence rates observed over winter 2022/23, or if these are better explained by the impact of COVID-19-related restrictions on population immunity and carriage of group A Streptococcus.

1 February 2016 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
KSK Salado-Rasmussen
K Salado-Rasmussen
SCS Cowan
S Cowan
JGJ Gerstoft
J Gerstoft
HLH Larsen
H Larsen
SHS Hoffmann
S Hoffmann
JJJ Jensen
J Jensen
The aim of this nationwide study is to determine the strain type diversity among patients diagnosed with syphilis by PCR during a 4-year per...

27 December 2012 in Sexually Transmitted Infections
Verified
Journal Article
Closed access
PDF file
KSKirsten Salado-Rasmussen
Kirsten Salado-Rasmussen
TKTerese Lea Katzenstein
Terese Lea Katzenstein
JGJan Gerstoft
Jan Gerstoft
SCSusan Alice Cowan
Susan Alice Cowan
TKTroels Bygum Knudsen
Troels Bygum Knudsen
NONiels Obel
Niels Obel
Objectives Risk of subsequent diagnosis of HIV in persons diagnosed with newly acquired syphilis, and syphilis in HIV-infected persons, are of interest as these infections are markers of unsafe sex. Methods From a nationwide register, all Danish men aged >16 years diagnosed with syphilis in the period 2000–2010 (n=1217) were identified, and subsequently data on HIV status was extracted from the Danish HIV Cohort Study. We used Kaplan–Meier analysis to estimate the 5-year risk of HIV and second syphilis infection, and Cox regression to determine incidence rate ratios (IRR). Results The 5-year risk of HIV diagnosis was 9.8% (95% CI 7.0% to 12.6%). Those with a second diagnosis of syphilis had a higher risk of being diagnosed with HIV (IRR=3.1, 95% CI 1.2 to 8.0). The 5-year risk for a second diagnosis of syphilis was 14.8% (95% CI 12.1% to 17.4%) and HIV-infected persons had a higher risk of a second syphilis diagnosis (IRR=4.0, 95% CI 2.8 to 5.9). Sixty-five percent of the persons were men having sex with men (MSM). Thirty-four percent of the HIV-infected persons had viral load >1000 copies/ml at time of syphilis diagnosis. Conclusions The substantial risks of syphilis and HIV infection in men diagnosed with one of these sexually transmitted diseases indicate a high frequency of unsafe sex in the Danish MSM population. As one-third of the HIV-infected persons diagnosed with syphilis had high viral loads, our data support initiation of antiretroviral therapy in all HIV-infected MSM to reduce HIV transmission.

25 March 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MCMichelle J. Cole
Michelle J. Cole
NQNerteley Quaye
Nerteley Quaye
SJSusanne Jacobsson
Susanne Jacobsson
MDMichaela Day
Michaela Day
EFElizabeth Fagan
Elizabeth Fagan
MUMagnus Unemo
Magnus Unemo
Confidence in any diagnostic and antimicrobial susceptibility testing data is provided by appropriate and regular quality assurance (QA) procedures. In Europe, the European Gonococcal Antimicrobial Susceptibility Programme (Euro-GASP) has been monitoring the antimicrobial susceptibility in Neisseria gonorrhoeae since 2004. Euro-GASP includes an external quality assessment (EQA) scheme as an essential component for a quality-assured laboratory-based surveillance programme. Participation in the EQA scheme enables any problems with the performed antimicrobial susceptibility testing to be identified and addressed, feeds into the curricula of laboratory training organised by the Euro-GASP network, and assesses the capacity of individual laboratories to detect emerging new, rare and increasing antimicrobial resistance phenotypes. Participant performance in the Euro-GASP EQA scheme over a 10 year period (2007 to 2016, no EQA in 2013) was evaluated. Antimicrobial susceptibility category and MIC results from the first 5 years (2007–2011) of the Euro-GASP EQA were compared with the latter 5 years (2012–2016). These time periods were selected to assess the impact of the 2012 European Union case definitions for the reporting of antimicrobial susceptibility. Antimicrobial susceptibility category agreement in each year was ≥91%. Discrepancies in susceptibility categories were generally because the MICs for EQA panel isolates were on or very close to the susceptibility or resistance breakpoints. A high proportion of isolates tested over the 10 years were within one (≥90%) or two (≥97%) MIC log2 dilutions of the modal MIC, respectively. The most common method used was Etest on GC agar base. There was a shift to using breakpoints published by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) in the latter 5 years, however overall impact on the validity of results was limited, as the percentage categorical agreement and MIC concordance changed very little between the two five-year periods. The high level of comparability of results in this EQA scheme indicates that high quality data are produced by the Euro-GASP participants and gives confidence in susceptibility and resistance data generated by laboratories performing decentralised testing.

19 December 2020 in Immunology
Verified
Journal Article
Closed access
PDF file
JJJens Magnus Bernth Jensen
Jens Magnus Bernth Jensen
SSSune Skeldal
Sune Skeldal
MPMikkel Steen Petersen
Mikkel Steen Petersen
BMBjarne Kuno Møller
Bjarne Kuno Møller
SHSteen Hoffmann
Steen Hoffmann
STSteffen Thiel
Steffen Thiel

15 February 2024 in Eurosurveillance
Verified
Journal Article
Open access
TPThomas Roland Pedersen
Thomas Roland Pedersen
MWMaria Wessman
Maria Wessman
MLMikkel Lindegaard
Mikkel Lindegaard
SHSøren Hallstrøm
Søren Hallstrøm
CWCasper Westergaard
Casper Westergaard
MSMarc Stegger
Marc Stegger
A surge in gonorrhoea in Denmark has occurred since 2022, a 46% increase from 2021. National surveillance, leveraging mandatory reporting and epidemiological data, highlights three distinct clades linked to heterosexual transmission. Despite the rise, these exhibit high susceptibility, contrasting MSM-associated strains. Geographical hotspots and age-specific patterns further illuminate transmission dynamics. The combination of genomic and epidemiological data provides novel insights into the evolving landscape of gonorrhoea, indicating potential shifts in infection dynamics and transmissibility.